Lenacapavir, which protects people from H.I.V. infection with twice-yearly shots, is arriving in a country where the health system has been hollowed out by American aid cuts.
Lenacapavir, which protects people from H.I.V. infection with twice-yearly shots, is arriving in a country where the health system has been hollowed out by American aid cuts.
<iframe src="https://statesidedaily.com/embed/cluster/5a0883b5e261edb7eaf18ce5e7fb8079a97f0207" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="A Powerful H.I.V. Drug Lands in Zambia. But Will It Reach Those Who Need It?"></iframe>
Lenacapavir, which protects people from H.I.V. infection with twice-yearly shots, is arriving in a country where the health system has been hollowed out by American aid cuts.
